SINGAPORE: German company Evonik Industries on Wednesday (Oct 19) held a groundbreaking ceremony for its second methionine plant in Singapore.
The company will invest more than €500 million (S$761 million) in the plant, which will have a production capacity of 150,000 metric tons a year. This brings the company’s annual production capacity in Singapore to 300,000 metric tons, and to around 730,000 metric tons globally.
The Me6 plant on Jurong Island is slated to be completed by 2019, and will be Evonik's sixth global methionine facility. Methionine is an amino acid used in animal feed, such as for chickens and pigs.
Dr Reiner Beste, chairman of the board of management at Evonik Nutrition and Care, said Singapore was chosen for its logistics infrastructure, as well as support from the regulatory authorities and engineering partners. Evonik’s first plant was competed two years ago.
Speaking at the groundbreaking ceremony, Deputy Prime Minister and Coordinating Minister for Economic and Social Policies Tharman Shanmugaratnam said Evonik's investment is a "statement of confidence in Singapore as a location for high-value manufacturing”. Such plants are typically built once every seven to eight years, he added.
Mr Tharman also noted that Evonik is investing in technology and innovation, which will help create quality jobs. Evonik will be training and developing a strong Singaporean core, he said.
"It complements our broader efforts to develop the skills needed for the jobs of the future," Mr Tharman said.
The new production complex is expected to add 150 jobs – mainly engineering jobs – to Evonik's methionine production operations in Singapore, which already hires 200 people at its existing plant.